Share
Share on facebook
Share on twitter

Characterization of Malignant Portal Vein Thrombosis with Contrast Enhanced Ultrasonography

January, 2019 — Ultrasound in Medicine and Biology

Abstract

We prospectively evaluated the effectiveness of contrast-enhanced ultrasonography (CEUS) for differentiation of benign versus malignant portal vein thrombosis (PVT). We studied a total of 43 patients with chronic liver disease, hepatocellular carcinoma-suggestive nodules and confirmed PVT, in whom the nature of the PVT was confirmed by follow-up imaging (US, computed tomography and/or magnetic resonance imaging) performed up to 6 mo after CEUS. PVT was assessed by US, Doppler US and CEUS with respect to vessel wall disruption and/or invasion, color Doppler vascularization, pulsed Doppler vascularization pattern and CEUS enhancement and vascularization pattern, and thrombi were classified as benign or malignant based on these findings. Follow-up studies revealed malignant PVT in 22 of the 43 patients (51%) and benign PVT in 21 patients (49%). CEUS findings were consistent with follow-up studies in 41 of the 43 patients (95%), with κ = 0.903 (p < 0.0001), sensitivity = 91% and specificity = 100%, indicating that CEUS can be confidently used to differentiate benign from malignant portal vein thrombosis in the setting of chronic liver disease.

Authors; Maria C. Chammas; Andre C. Oliveira; Mario J D´Ávilla; Pedro H. Moraes; Marcelo Straus Takahashi

Ultrasound Division, Department of Radiology, Hospital das Clınicas, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil; and Liver Surgery Division, Department of Surgery, Hospital das Clınicas, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil

January 2019, Volume 45, Issue1, Pages 50–55

Be Part of our Community

ICUS Membership is free.

ICUS Connect

FREE
VIEW